Mitochondria control of cell death induced by anti-HLA-DR antibodies

Leukemia

Volumn 17, Issue 7, 2003, Pages 1357-1365

  Bains, S K ^a   Mone, A ^b   Yun Tso, J ^a   Lucas, D ^b   Byrd, J C ^b   Weiner, G J ^c   Green, J M ^a  

^a PROTEIN DESIGN LABS INC   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Apoptosis inducing factor; Caspase independent; HLA DR; Hu1D10; Programmed cell death

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIBODY; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; EXPOSURE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL;

EID: 0038442313     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402976     Document Type: Article

References (38)

1. Kostelny SA, Link BK, Tso JY, Vasquez M, Jorgensen BH, Wang H et al. Humanization and characterization of the anti-HLA-DR antibody 1D10. Int J Cancer 2001; 93: 556-565.
2. Shi JD, Bullock C, Hall WC, Wescott V, Wang H, Levitt DJ et al. In vivo pharmacodynamic effects of Hu1D10 (Remitogen), a humanized antibody reactive against a polymorphic determinant of HLA-DR expressed on B cells. Leukemia Lymphoma 2002; 43: 1303-1312.
3. Link BK, Wang H, Byrd JC, Leonard JP, Davis TA, Flinn I et al. Phase I study of Hu1D10 monoclonal antibody in patients with B-cell lymphoma. ASCO 2001; 1135.
4. Link BK, Wang H, Byrd JC, Leonard JP, Flinn I, Davis TA et al. Humanized anti-HLA-DR monoclonal antibody Hu1D10 for the treatment of relapsed non-Hodgkin's lymphoma: a phase I trial. ASH 2001; 4703.
5. Abhyankar VV, Lucas MS, Lin TS, Mone A, Stock W, Aron JL et al. Phase I study of thrice weekly dosing of Hu1D10 in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): preliminary observations in toxicity and biologic data. ASCO 2002; 1069
6. Drenou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol 1999; 163: 4115-4124.
7. Nagy ZA, Hubner B, Lohning C, Rauchenberger R, Reiffert S, Thomassen-Wolf E et al. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat Med 2002; 8: 801-807.
8. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
9. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2: 589-598.
10. Truman J, Ericson ML, Choqueux-Seebold JM, Charron DJ, Mooney NA. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 1994; 6: 887-896.
11. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
12. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
13. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000; 192: 571-580.
14. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781-828.
15. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
16. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-347.
17. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
18. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627-637.
19. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-165.
20. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 1998; 187: 1261-1271.
21. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-2031.
22. Genini D, Adachi S, Chao Q, Rose DW, Carrera CJ, Cottam HB et al. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. Blood 2000; 96: 3537-3543.
23. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-4714.
24. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO 1998; 17: 37-49.
25. Scaffidi C, Kirchhoff S, Krammer PH, Peter ME. Apoptosis signaling in lymphocytes. Curr Opin Immunol 1999; 11: 277-285.
26. Dumont C, Durrbach A, Bidere N, Rouleau M, Kroemer G, Bernard G et al. Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult. Blood 2000; 96: 1030-1038.
27. Deas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F et al. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol 1998; 161: 3375-3383.
28. Petit F, Arnoult D, Lelievre JD, Moutouh-de Parseval L, Hance AJ, Schneider P et al. Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death. J Biol Chem 2002; 277: 1477-1487.
29. Lesage S, Steff AM, Philippoussis F, Page M, Trop S, Mateo V et al. CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway. J Immunol 1997; 159: 4762-4771.
30. Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP. CD47 signals T cell death. J Immunol 1999; 162: 7031-7040.
31. Pettersen RD, Bernard G, Olafsen MK, Pourtein M, Lie SO. CD99 signals caspase-independent T cell death. J Immunol 2001; 166: 4931-4942.
32. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410: 549-554.
33. Kim SM, Shin KH, Fujiwara T, Akutsu H. The interaction of ferric and ferrous cytochrome c with cardiolipin in phospholipid membranes studied by solid-state H-2 and P-31 NMR. J Mol Struct 1998; 441: 183-188.
34. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182: 367-377.
35. Reed JC, Green DR. Remodeling for demolition: changes in mitochondrial ultrastructure during apoptosis. Mol Cell 2002; 9: 1-3.
36. Pardo J, Perez-Galan P, Gamen S, Marzo I, Monleon I, Kaspar AA et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol 2001; 167: 1222-1229.
37. Mathas S, Rickers A, Bommert K, Dorken B, Mapara MY. Anti-CD20 and B-cell receptor mediated apoptosis: evidence for shared intracellular signaling pathways. Cancer Res 2000; 60: 7170-7176.
38. Shan D, Ledbetter JA, Press OW. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol Immunother 2000; 48: 673-683.